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Background: Breast neoplasms include different histopathological entities, varying from benign tumors to highly
aggressive cancers. Despite the key role of imaging, traditional histology is still required for a definitive diagnosis.
Confocal Laser Endomicroscopy (CLE) is a new technique, which enables to obtain histopathological images in vivo,
currently used in the diagnosis of gastrointestinal diseases. This is a single-center pilot feasibility study; the main
aim is to describe the basic morphological patterns of Confocal Laser Endomicroscopy in normal breast tissue
besides benign and malignant lesions.
Methods: Thirteen female patients (mean age 52.7, range from 22 to 86) who underwent surgical resection for a
palpable breast nodule were enrolled. CLE was performed soon after resection with the Cellvizio® Endomicroscopy
System (Mauna Kea Technologies, Paris, France), by using a Coloflex UHD-type probe; intravenous fluorescein was
used as contrast-enhancing agent. The surgical specimen was cut along the main axis; dynamic images were
obtained and recorded using a hand-held probe directly applied both to the internal part of the lesion and to
several areas of surrounding normal tissue. Each specimen was then sent for definitive histologic examination.
Results: Histopathology revealed a benign lesion in six patients (46%), while a breast cancer was diagnosed in
seven women (54%). Confocal laser endomicroscopy showed some peculiar morphological patterns. Normal breast
tissue was characterized by a honeycomb appearance with regular, dark, round or hexagonal glandular lobules on a
bright stroma background; tubular structures, representing ducts or blood vessels, were also visible in some frames.
Benign lesions were characterized by a well-demarcated “slit-like” structure or by lobular structures in abundant
bright stroma. Finally, breast cancer was characterized by a complete architectural subversion: ductal carcinoma was
characterized by ill-defined structures, with dark borders and irregular ductal shape, formingribbons, tubules or
nests; mucinous carcinoma showed smaller cells organized in clusters, floating in an amorphous extracellular matrix.
Conclusions: This is the first pilot study to investigate the potential role of confocal laser imaging as a diagnostic tool in
breast diseases. Further studies are required to validate these results and establish the clinical impact of this technique.Background
Breast neoplasms include different histopathological en-
tities, varying from benign tumors to highly aggressive
cancers. Clinical aspects of breast lesions include nod-
ules, lumps or cysts; the possibility to differentiate be-
tween benign and malignant lesions is a key factor in
order to establish the proper management protocol and
determine whether surgery is needed. Mammography,* Correspondence: giovanni.depalma@unina.it
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unless otherwise stated.Ultrasonography and even MRI are commonly used in
breast diseases work-up; however, despite the accuracy
of modern imaging, traditional histology is still required
for a definitive diagnosis.
Ultrasonography, X-ray and MRI are used for targeted bi-
opsies, but excisional biopsy is often required nonetheless.
Confocal Laser Endomicroscopy (CLE) is a relatively
new technique that enables real-time histopathology of
human tissues. Confocal microscopy is based on focus-
ing a laser beam (such as an argon-ion laser that gener-
ates an excitation wavelength of 488 nm, blue laser light)
into a plane of interest; the returning light is filteredral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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De Palma et al. BMC Cancer  (2015) 15:252 Page 2 of 7through a small pinhole that rejects the out-of-focus light.
Illumination and detection systems operate in the same
focal plane and are referred as “confocal”. After passing the
pinhole, the fluorescent light is detected by a photo-
detection device that transforms the light signal into an
electrical one that is recorded by a computer system. All
signals coming from illuminated spots are captured and
measured. Laser scanning over a plane of interest allows to
obtain a pixel-by-pixel and line-by-line image, whereas the
brightness of each single pixel corresponds to the relative
intensity of the detected fluorescent light. A gray scale
image is created which corresponds to an optical section
and represents the focal plane within the examined speci-
men. A fluorescent dye (contrast agent) is required to make
confocal images visible: contrast agents can be administered
systemically (fluorescein, tetracycline) or topically (acrifla-
vine, cresyl violet), using a spraying catheter. Intravenous
fluoresceinsodium (10%) and topically applied acriflavine
(0.2%) have been most commonly used in humans [1,2].
CLE has been first applied in the field of gastrointestinal
endoscopy, showing to be a very useful tool in targeted bi-
opsies, thus reducing the number of samples and increas-
ing the diagnostic accuracy, especially in clinical settings
such as Barrett’s Esophagus, Ulcerative Colitis and early
identification of dysplasia [3-6]. Recently, applications in
gastrointestinal surgery, pulmonology and neurosurgery
have also been described [7-10].
The aim of the present study was to describe the basic
morphological patterns at CLE in normal breast tissue
and in benign and malignant lesions; this might represent
the first step for further investigation into assessing the
role of CLE as a diagnostic tool in breast diseases.Methods
General study design
This is a prospective, single-center, pilot-study; the primary
aim was to describe typical morphological patterns in nor-
mal breast tissue and in benign and malignant lesions at
CLE (confocal laser endomicroscopy). The feasibility of
CLE combined with video-mosaicing was also investigated,
together with its ability to differentiate between normal, be-
nign and malignant breast tissue. The secondary aim was
to investigate the ideal timing for fluoresceine i.v. infusion
before specimen resection, when fluoresceine is used as
contrast-enhancing agent. The study was approved by the
internal institutional review board “Carlo Romano” (proto-
col n. 276/2013). A signed informed consent was obtained
from all the patients enrolled in the study.Patients
All patients, as from inclusion criteria, were older than 18
and had breast lesion requiring surgical excision. Exclusion
criteria were: pregnancy, allergy to fluorescein or drugs,chronic renal failure, inability to understand the study
protocol.
Equipment
CLE was performed by using the Cellvizio® Endomicro-
scopy System (Mauna Kea Technologies, Paris, France)
with a Coloflex UHD-type probe (1 μm lateral resolution;
12 frames/s). This probe has a 240 μm× 200 μm field of
view, with a lateral resolution of 1 μm. CLE imaging data
were collected at a 12 frames/s scan rate, the scanning
field being of 30 000 pixels.
Tissue examination
All the patients with malignant lesions were treated with
quadrantectomy; a simple excision was performed in case
of benign nodules. During surgery, patients received 5 ml
of intravenous 10% fluorescein, about 5 minutes before
the specimen excision (time range: 2 to 10 minutes).
The surgical specimen was examined by CLE immedi-
ately after the resection. The specimen was cut along the
main axis and dynamic images were collected by using
the hand-held probe, applied directly both to the in-
ternal part of the lesion and to several areas of sur-
rounding normal tissue. Care was taken while examining
the margins of the lesion in order to recognize the tran-
sition between normal and neoplastic tissue.
Confocal laser imaging was carefully analyzed in order
to describe cellular morphology and cellular structures of
specimens. Differences between macroscopically normal
or neoplastic tissue were evaluated in real time, in order
to describe peculiar morphological patterns attributing
them to normal tissue, benign or malignant lesions.
Proper timing for i.v.fluorescein infusion has also been
assessed, in order to establish the best interval from
fluorescein infusion to specimen resection. All the im-
ages and mosaics were stored in the Cellvizio® Endomi-
croscopy System database. Specimens were then sent for
traditional histology.
Results
Thirteen female patients were enrolled with a mean age of
52.7 (range 22 – 86). A fibroepithelial lesion was diag-
nosed in six patients (46%): 4 of them had a fibroadenoma
and 2 had a benign phyllodes tumor. An invasive breast
cancer was diagnosed in seven patients (54%): five patients
had a ductal carcinoma, one patient had a lobular carcin-
oma and one patient a mucinous carcinoma (Table 1).
Morphological pattern at confocal laser imaging
Normal breast tissue was characterized by a honeycomb ap-
pearance, with regular, dark, round or hexagonal glandular
lobules on a bright stroma background; in some frames
there were also tubular structures, representing ducts or
blood vessels (Figure 1).
Table 1 Patients characteristics
N. Age Histology Receptor status° Grade (G)* Stage (TN)
1 22 Phylloid
2 55 Ductal Carcinoma ER 90%, PR 70%, Ki-67 15%, Her-2 neg G2 pT1, N0
3 74 Ductal Carcinoma ER 90%, PR 90%, Ki-67 5%, Her-2 3+ G3 pT1, Nx
4 30 Fibroadenoma
5 77 Ductal Carcinoma ER 90%, PR 2%, Ki-67 15%, Her-2 neg G3 pT2, N1
6 29 Fibroadenoma




11 75 Ductal Carcinoma ER 90%, PR 70%, Ki-67 25%, Her-2 neg G3 pT1, N0
12 86 Mucinous Carcinoma
13 71 Ductal Carcinoma ER 90%, PR 2%, Ki-67 15%, Her-2 neg G3 pT2, N1
°ER (estrogen receptor); PR (progesterone receptor) Her-2 (Human epidermal growth factor).
*Tumor Grading system: G1: well differentiated; G2: moderately differentiated; G3: poorly differentiated; G4: undifferentiated.
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demarcated, “slit-like”, lobular and darker structures in a
bright stroma; nuclei of fibroblast cells were also clearly
visible in some frames. “Slit-like” figures might be the
expression of compressed and irregular ducts typical of
intracanalicular fibroadenoma (Figure 2); on the other
hand, “lobular structures” are typical of pericanalicular
fibroadenoma, with a morphological pattern similar to
the one seen at traditional histology (Figure 3).
Malignancies were characterized by a complete architec-
tural subversion. Ductal carcinoma showed ill-defined
structures with dark borders and irregular ductal shape,Figure 1 p-CLE imaging of normal breast. a: CLE-fluorescein sodium 10% im
with regular dark round or hexagonal glandular lobules in a bright stroma ba
(arrow). b: Corresponding normal breast tissue (haematoxylin and eosin stainiforming ribbons, tubules or nests. Single, small infiltrating
cells were also present, thus forming a hypercellular
stroma (Figure 4). Mucinous carcinoma had similar fea-
tures with smaller cells organized in clusters and floating
in an amorphous background of extracellular mucin
(Figure 5).
We exclusively used fluoresceine as contrast-enhancing
agent; the major drawback of this agent is its difficulty in
highlighting cell nuclei, thus it was not possible to evaluate
the presence of mitotic figures and proliferation rate. Acri-
flavine is a different contrast-enhancing agent that is able to
penetrate into cell nuclei and might be useful to identifyaging of normal breast tissue characterized by a honeycomb appearance
ckground. A tubular structure representing a duct is visible in this frame
ng).
Figure 2 p-CLE imaging of intracanalicular fibroadenoma. a: CLE-fluorescein sodium 10% imaging showing well-demarcated “slit-like” structures
in an abundant bright stroma, representing irregular and compressed ducts. b: Corresponding histopathological image (haematoxylin and
eosin staining).
De Palma et al. BMC Cancer  (2015) 15:252 Page 4 of 7mitotic figures; unfortunately its use in-vivo is limited by a
mutagenic potential.
We initially used a short interval (2 minutes) between
fluorescein administration and specimen resection, which
we think resulted in poor image quality, especially forFigure 3 p-CLE imaging of pericanalicular fibroadenoma. a: CLE- fluorescei
ductal spaces in an abundant bright stroma. b: Corresponding histopatholobenign nodules; this was probably due to the hypovascu-
larization of such lesions. A five-minute interval seemed
to be required for optimal fluoresce in impregnation of
benign lesions. Figure 6 shows the poor image quality after
a “short” infusion interval and how the image-quality getsn sodium 10% imaging showing round or oval structures representing
gical image (haematoxylin and eosin staining).
Figure 4 p-CLE imaging of infiltrating ductal carcinoma. a: CLE- fluorescein sodium 10% imaging showing a complete architectural subversion,
with ill-defined structures, dark border and irregular ductal shape forming ribbons, tubules or nests. b: Corresponding histopathological image
(haematoxylin and eosin staining).
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significant differences in image quality was observed in
malignant lesions relating to different timing of infusion.
Discussion
Diagnosis of breast diseases is usually based on radiology
and traditional histopathology. The four-parameter 18-
FDG-PET/MRI has high accuracy in differential diagnosisFigure 5 p-CLE imaging of invasive mucinous carcinoma. a: CLE- fluoresce
floating in an amorphous extracellular mucin matrix. b: Corresponding histbetween benign and malignant neoplasms of breast, lead-
ing to a reduction of unnecessary biopsies [11].
The present pilot study showed, for the first time, that
CLE might be a useful tool in highlighting morpho-
logical features of normal breast, benign and malignant
lesions, thus anticipating histopathological diagnosis.
In this preliminary experience, benign lesions seemed
to require a longer interval from fluorescein i.v. infusionin sodium 10% imaging showing smaller cells organized in clusters,
opathological image (haematoxylin and eosin staining).
Figure 6 Evaluation of image quality with increasing injection-to-imaging time in benign breast lesions. Figure shows the poor image quality
after a “short” infusion interval (a: 2 min) and how it gets better when a longer (b: 5 min) interval has been used.
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finding may need further confirmation in larger sample
studies. Moreover, a different timing in fluorescein tissue
impregnation might be also used as an a adjunctive diag-
nostic criterion, in discriminating benign from malignant
lesions. We used fluorescein as contrast-enhancing
agent, which is the most common agent used to date.
However different fluorescent dyes are available (e.g.
acriflavine) that might be applied topically to highlight
cellular nuclei. Furthermore, different light sources like
NIR (near infrared probes) or dual wavelength light
sources could be used in the future to increase penetra-
tion depth of scanning light [12,13].
Further investigation in this field might lead to routine
use of in-vivo US-guided or radio-guided virtual biopsies;
new “needle probes” might be also required, similar to the
ones already in use in the field of US-Endoscopy [14,15].
Real time, in-vivo, virtual histology could significantly
decrease the time needed for a diagnosis or, at least, pro-
vide a useful tool in discriminating lesions that will require
further histological assessment.
An additional clinical use of virtual histology might be
the assessment of resection margins, immediately after the
surgical resection or even directly in the operating field,
thus saving time when extemporary histology would be re-
quired anyway. Something similar has been already pro-
posed in colorectal and neurosurgery [7,10].
Despite CLE produces “microscopy” images, it does not
generally require an expert pathologist interpretation; the
role of CLE has already been established in the field of
gastrointestinal endoscopy, where it has been demonstrated
to be a useful tool for surgeons or endoscopists in targeted
biopsies. Our experience demonstrates similar findings; we
believe that a training together with a dedicated pathologist
would be sufficient to learn how to discriminate the main
morphological patterns in order to differentiate between
malignant and benign lesions. On the other hand, the role
of CLE in the field of breast cancer needs to be further in-
vestigated. One might argue that once the skin is opened,CLE might not give any real advantages compared to trad-
itional histology with regard to invasiveness. We actually
see a potential role of this investigation in those situations
where an extemporaneous examination is required: CLE is
a time-saving examination, does not require sample prepar-
ation or staining and might allow the surgeon to achieve a
diagnostic orientation immediately at the operating table.
Conclusions
This is a pilot study to investigate the potential role of con-
focal laser imaging as diagnostic tool in breast diseases. Dif-
ferent morphological patterns at CLE examination have
been carefully described, both in benign and malignant
breast lesions. Further studies are needed to validate these
results and establish the clinical impact of this technique.
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